Mikhail A. Buldakov
Tomsk State University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mikhail A. Buldakov.
Immunobiology | 2017
Mikhail A. Buldakov; Marina V. Zavyalova; N. V. Krakhmal; Nadezhda Telegina; Sergei Vtorushin; Irina Mitrofanova; Vladimir Riabov; Shuiping Yin; Bin Song; Nadezhda V. Cherdyntseva; Julia Kzhyshkowska
Tumor associated macrophages (TAM) support tumor growth and metastasis in several animal models of breast cancer, and TAM amount is predictive for efficient tumor growth and metastatic spread via blood circulation. However, limited information is available about intratumoral TAM heterogeneity and functional role of TAM subpopulations in tumor progression. The aim of our study was to examine correlation of TAM presence in various morphological segments of human breast cancer with clinical parameters. Thirty six female patients with nonspecific invasive breast cancer T1-4N0-3M0 were included in the study. Morphological examination was performed using Carl Zeiss Axio Lab.A1 and MiraxMidiZeiss. Immunohistochemical and immunofluorescence/confocal microcopy analysis was used to detect CD68 and stabilin-1 in 5 different tumor segments: (1) areas with soft fibrous stroma; (2) areas with coarse fibrous stroma; (3) areas of maximum stromal-and-parenchymal relationship; (4) parenchymal elements; (5) gaps of ductal tumor structures. The highest expression of CD68 was in areas with soft fibrous stroma or areas of maximum stromal-and-parenchymal relationship (79%). The lowest expression of CD68 was in areas with coarse fiber stroma (23%). Inverse correlation of tumor size and expression of CD68 in gaps of tubular tumor structures was found (R=-0.67; p=0.02). In case of the lymph node metastases the average score of CD68 expression in ductal gaps tumor structures was lower (1.4±0.5) compared to negative lymph nodes case (3.1±1.0; F=10.9; p=0.007). Confocal microscopy identified 3 phenotypes of TAM: CD68+/stabilin-1-; CD68+/stabilin-1+ (over 50%); and CD68-/stabilin-1+. However, expression of stabilin-1 did not correlate with lymph node metastasis. We concluded, that increased amount of CD68+TAM in gaps of ductal tumor structures is protective against metastatic spread in regional lymph nodes.
Immunobiology | 2017
Irina Mitrofanova; Marina V. Zavyalova; Nadezhda Telegina; Mikhail A. Buldakov; Vladimir Riabov; Nadezhda V. Cherdyntseva; Julia Kzhyshkowska
Breast cancer is the leading cause of cancer death in women worldwide with high morbidity and mortality. Tumor-associated macrophages (TAM) are major innate immune cells in the tumor microenvironment controlling primary tumor growth and metastasis. Neoadjuvant chemotherapy (NACT) is a conventional pre-operative treatment for breast cancer. In the present study we examined the distribution of TAM in five distinct intratumoral morphological compartments of human breast cancer and their correlation with clinical parameters after NACT. Our data indicated that CD68+ but not stabilin-1+ TAM in areas with parenchymal elements negatively correlate with lymphatic metastasis after NACT. However, in cases where lymphatic metastases were detected (28 out of 50 analyzed samples) both amount of CD68+ and stabilin-1+ macrophages in the areas with coarse fibrous stroma directly correlated with the number of positive lymph nodes. In patients with complete response to the preoperative NACT the average score of CD68 expression in the areas with coarse fibrous stroma was lower compared with cases of a partial response and stable disease. We concluded that function of TAM after NACT depends on their intratumoral localization and local tumor microenvironment which plays an important role in polarization of macrophages towards tumor-suppressive or tumor-supportive types.
Ultrasonics Sonochemistry | 2015
Mikhail A. Buldakov; Mariame A. Hassan; Paras Jawaid; Nadejda V. Cherdyntseva; Takashi Kondo
Previously, we have shown that a combination between X-irradiation and low-intensity pulsed ultrasound (US) could synergistically suppress cell survival post exposure (Buldakov et al., 2014). In this study, the cellular effects underlying the enhanced cell killing are investigated. U937 and Molt-4 cell lines were exposed to 1.0 MHz US with 50% duty factor at 0.3 W/cm(2) and pulsed at 1, 5 and 10 Hz immediately after exposure to X-rays at 0, 0.5, 2.5 and 5 Gy. The cells were assayed at different time points to depict the major cellular events that culminated in cell death. For instance, membrane damage and cell lysis were estimated immediately following exposure and 24 h later. Intracellular reactive oxygen species (ROS) were also determined flow cytometrically after treatment. Moreover, the extent of DNA damage and cell cycle progression were determined at 6 and 24 h, respectively. Despite the general trend for synergism, there was a disproportionation of mediating factors depending on the cell type and its specific biological makeup. Immediately, US could induce appreciable necrotic cell death through extensive membrane damage in U937 but induced cell lysis in Molt-4 cells. ROS might have contributed to cell killing in Molt-4 but not in U937 cells. Although both of the physical modalities are significantly DNA-damaging alone, no additional damage was observed in combination. Moreover, override in some arrested cell cycle phases was also observed following combination. Collectively, the interaction between X-rays and US seems to depend mainly on the acoustic environment determined by the setup and this might explain the contradictory data among reports.
Thermal Medicine | 2007
吉田 徹; 近藤 隆; 小川 良平; Qing-Li Zhao; Mariame A. Hassan; 渡部 明彦; 高崎 一朗; 田渕 圭章; 庄司 美樹; 工藤 信樹; Loreto B. Feril; 立花 克郎; Mikhail A. Buldakov; 本田 昂; 塚田 一博; Peter Riesz
Interest in molecular imaging and in molecularly-targeted therapy has grown tremendously, and ultrasound may offer new tools for modern cancer therapy. To understand how therapeutic ultrasound works, it is necessary to understand its biological effects at the molecular level. In this review,investigations on the molecular aspects of ultrasound are discussed,with emphasis on apoptosis induction,gene expression,and gene transfection. In these studies,apoptosis induction was assayed with flow cytometry and with other methods targeting indicators of apoptosis. Gene expression was evaluated using western blotting,real-time polymerase chain reaction,and microarray analysis. Gene transfection was investigated using a luciferase assay and other methods. The reported results show that low intensity ultrasound can induce apoptosis in cancer cell lines,and that this effect can be optimized using pulsed ultrasound. Exposure to ultrasound can result in the down-regulation or up-regulation of some genes. Of particular interest is the striking up-regulation of the heme oxygenase-1 gene,a gene usually associated with oxidative stress in human lymphoma U937 cells. Introducing genes using Molecular therapy utilizing ultrasound・T.Yoshida et al. ― ― 113 Received 3 July 2007,Accepted 20 August 2007. Corresponding author;Tel,+81-76-434-7265;Fax,+81-76-434-5190; e-mail,[email protected] doi:10.3191/thermalmed.23.113 ©2007 Japanese Society for Thermal Medicine ultrasound with or without microbubbles also exhibited promising results. Membrane damage is pivotal to biological effects,and using ultrasound to modify or affect cell membranes can either promote or inhibit desired effects. In summary,it is concluded that ultrasound has the potential to help develop useful methods which can be utilized in therapies which require apoptosis induction,gene introduction into cells,alterations in gene regulation,and drug-activation.
Oncotarget | 2017
Evgeny V. Denisov; Nikolay A. Skryabin; Tatiana S. Gerashchenko; Lubov A. Tashireva; Jochen Wilhelm; Mikhail A. Buldakov; Aleksei A. Sleptcov; Igor N. Lebedev; Sergey V. Vtorushin; Marina V. Zavyalova; Nadezhda V. Cherdyntseva; Vladimir M. Perelmuter
Intratumor morphological heterogeneity in breast cancer is represented by different morphological structures (tubular, alveolar, solid, trabecular, and discrete) and contributes to poor prognosis; however, the mechanisms involved remain unclear. In this study, we performed 3D imaging, laser microdissection-assisted array comparative genomic hybridization and gene expression microarray analysis of different morphological structures and examined their association with the standard immunohistochemistry scorings and CD44+CD24- cancer stem cells. We found that the intratumor morphological heterogeneity is not associated with chromosomal aberrations. By contrast, morphological structures were characterized by specific gene expression profiles and signaling pathways and significantly differed in progesterone receptor and Ki-67 expression. Most importantly, we observed significant differences between structures in the number of expressed genes of the epithelial and mesenchymal phenotypes and the association with cancer invasion pathways. Tubular (tube-shaped) and alveolar (spheroid-shaped) structures were transcriptionally similar and demonstrated co-expression of epithelial and mesenchymal markers. Solid (large shapeless) structures retained epithelial features but demonstrated an increase in mesenchymal traits and collective cell migration hallmarks. Mesenchymal genes and cancer invasion pathways, as well as Ki-67 expression, were enriched in trabecular (one/two rows of tumor cells) and discrete groups (single cells and/or arrangements of 2-5 cells). Surprisingly, the number of CD44+CD24- cells was found to be the lowest in discrete groups and the highest in alveolar and solid structures. Overall, our findings indicate the association of intratumor morphological heterogeneity in breast cancer with the epithelial-mesenchymal transition and CD44+CD24- stemness and the appeal of this heterogeneity as a model for the study of cancer invasion.Intratumor morphological heterogeneity in breast cancer is represented by different morphological structures (tubular, alveolar, solid, trabecular, and discrete) and contributes to poor prognosis; however, the mechanisms involved remain unclear. In this study, we performed 3D imaging, laser microdissection-assisted array comparative genomic hybridization and gene expression microarray analysis of different morphological structures and examined their association with the standard immunohistochemistry scorings and CD44+CD24- cancer stem cells. We found that the intratumor morphological heterogeneity is not associated with chromosomal aberrations. By contrast, morphological structures were characterized by specific gene expression profiles and signaling pathways and significantly differed in progesterone receptor and Ki-67 expression. Most importantly, we observed significant differences between structures in the number of expressed genes of the epithelial and mesenchymal phenotypes and the association with cancer invasion pathways. Tubular (tube-shaped) and alveolar (spheroid-shaped) structures were transcriptionally similar and demonstrated co-expression of epithelial and mesenchymal markers. Solid (large shapeless) structures retained epithelial features but demonstrated an increase in mesenchymal traits and collective cell migration hallmarks. Mesenchymal genes and cancer invasion pathways, as well as Ki-67 expression, were enriched in trabecular (one/two rows of tumor cells) and discrete groups (single cells and/or arrangements of 2-5 cells). Surprisingly, the number of CD44+CD24- cells was found to be the lowest in discrete groups and the highest in alveolar and solid structures. Overall, our findings indicate the association of intratumor morphological heterogeneity in breast cancer with the epithelial-mesenchymal transition and CD44+CD24- stemness and the appeal of this heterogeneity as a model for the study of cancer invasion.
Mutation Research-genetic Toxicology and Environmental Mutagenesis | 2015
Nikolai V. Litviakov; Maxim B. Freidin; Aleksey E. Sazonov; Maria V. Khalyuzova; Mikhail A. Buldakov; Mikhail S. Karbyshev; Еlena N. Albakh; Daria S. Isubakova; Аleksey A. Gagarin; Gennadiy B. Nekrasov; Elena B. Mironova; Аndrey S. Izosimov; Ravil M. Takhauov; Аndrei B. Karpov
The study aimed to reveal cancer related mutations in DNA repair and cell cycle genes associated with chronic occupational exposure to gamma-radiation in personnel of the Siberian Group of Chemical Enterprises (SGCE). Mutations were analyzed by comparing genotypes of malignant tumors and matched normal tissues of 255 cancer patients including 98 exposed to external gamma-radiation (mean dose 128.1±150.5mSv). Also a genetic association analysis was carried out in a sample of 149 cancer patients and 908 healthy controls occupationally exposed to gamma-radiation (153.2±204.6mSv and 150.5±211.2mSv, respectively). Eight SNPs of genes of DNA excision repair were genotyped (rs13181, rs1052133, rs1042522, rs2305427, rs4244285, rs1045642, rs1805419 and rs1801133). The mutation profiles in heterozygous loci for selected SNP were different between sporadic tumors and tumors in patients exposed to radiation. In sporadic tumors, heterozygous genotype Arg/Pro of the rs1042522 SNP mutated into Arg/0 in 15 cases (9.6%) and 0/Pro in 14 cases (8.9%). The genotype Lys/Gln of the rs13181 SNP mutated into Lys/0 and 0/Gln in 9 and 4 cases, respectively. In tumors of patients exposed to low-level radiation, the rs1042522 Arg/0 mutated genotype was found in 12 cases (12.1%), while in 2 cases (2%) 0/Pro mutation was observed. Finally, the rs13181 0/Gln mutated genotype was observed in 15 cases (16,5%) . Thus, our study showed the difference in patterns of allelic imbalance in tumors appeared under low-level radiation exposure and spontaneous tumors for selected SNPs. This suggests different mechanisms of inactivation of heterozygous genotypes in sporadic and radiation-induced tumors.
Ultrasonics Sonochemistry | 2009
Mikhail A. Buldakov; Mariame A. Hassan; Qing-Li Zhao; Loreto B. Feril; Nobuki Kudo; Takashi Kondo; Nikolai V. Litvyakov; Mikhail A. Bolshakov; V. V. Rostov; Nadejda V. Cherdyntseva; Peter Riesz
Journal of Controlled Release | 2010
Mariame A. Hassan; Mikhail A. Buldakov; Ryohei Ogawa; Qing Li Zhao; Yukihiro Furusawa; Nobuki Kudo; Takashi Kondo; Peter Riesz
Pathology & Oncology Research | 2014
Evgeniya S. Grigoryeva; Nadezhda V. Cherdyntseva; Mikhail S. Karbyshev; Viktor V. Volkomorov; Ivan V. Stepanov; Marina V. Zavyalova; Vladimir M. Perelmuter; Mikhail A. Buldakov; Sergey G. Afanasjev; Sergey A. Tuzikov; Yulia A. Bukurova; Nikolai A. Lisitsyn; S. F. Beresten
Ejc Supplements | 2015
Marina V. Zavyalova; Mikhail A. Buldakov; N. Krakhmal; Nadezhda Telegina; Sergey V. Vtorushin; Nadezhda V. Cherdyntseva; Julia Kzhyshkowska